Dr. Galal Ashraf Elsayed, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 56-45 Main Street, Department Of Neurosurgery, Flushing, NY 11355 Phone: 718-670-0002 |
Dr. Harrison Te Ming Mu, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 13620 38th Ave Ste 6a, Flushing, NY 11354 Phone: 718-888-1107 Fax: 718-461-5765 |
Dr. Jaime H Nieto, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5620 Main St, Flushing, NY 11355 Phone: 718-670-1837 Fax: 718-661-7186 |
Dr. Murisiku Raifu, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5645 Main St, Rm-m204, Flushing, NY 11355 Phone: 718-445-0220 Fax: 718-939-1167 |
Dr. John K Park, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1837 Fax: 805-682-1844 |
Dr. Peter Hollis, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5580 |
Ingrid Benites, RN Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5620 Main St, Flushing, NY 11355 Phone: 718-670-1837 |
News Archive
USAID on Monday said it has "delivered the first two of 17 planned laboratory devices" to help quickly diagnose drug-resistant strains of tuberculosis (TB), VOA's "Breaking News" blog reports.
Rockefeller University scientists have discovered that the same enzyme that enables the immune system's defensive creativity is also responsible for a particular genetic malfunction - a translocation of one piece of DNA to the wrong chromosome - that causes Burkitt's lymphoma.
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
A new technique offers better sensitivity and accuracy in detecting an essential biomarker of cancer and inflammatory diseases.
WellCare Health Plans, Inc. today reported results for the third quarter and nine months ended September 30, 2009. As determined under generally accepted accounting principles ("GAAP"), the Company reported net income of $28.7 million, or $0.68 per diluted share, for the third quarter 2009, compared with a net loss of $18.2 million, or $0.44 per diluted share, for the third quarter 2008.
› Verified 5 days ago